Member Info for bobbust

All this share needs is that picture of a fully loaded train and its up 25%

by year end they will be mining 70,000 t a month 840,000 a year profit at present closer to $300/ton
thats $250m profit a year MC at present £296m.
And on top of that there is room for growth.
topping up now

of a fully loaded train in the near future

I bet a few £ we may see 1st modi1 patient next week.
From a quick glance British bulls wrong 50% of the time

they stated the next lot of transformers were ordered for delivery early 2023 .
this must mean next phase Q1/2 2023

They are both in for a lot more than a few pence.
They have so many shares they can only off load after big news.
And I mean BIG news.
Sclp have 3 trails ongoing. They would be mad to sell now

i think ben has gone up every Friday since early Feb.
will it rise tomorrow as its the last day of the week
My guess is people buying incase there is a RNS at the start of the following week

It has 2 likes.
2!!!
And one is me.
Least you all can do is like there tweets

more gold!!
looks promising

At £1 it's 10x Ipo and there will be lots hanging on for a £1.
But the numbers still point to £2 to £3 in less than a year

20 centers
And protocol amendments to make recrutment easier and results quicker

to make money.
my guess is they have done there due diligence and more reserch than most here.
also pro investers are not worried this is down below IPO price they will still think this is going to be above that level one day.
they wont even check the SP on a day to day basis

another master trader.
how is your oex rockets?

only need bid of 18p to be my best single day ever

from looking at your recent post you are wrong more often than right

why would a company with £35m in the bank (31-oct) whith a cash burn of £5m for 6
months need cash.
you dont know what you are talking about.
Lots of possable deals in the next 6m.
real proof will bring real deals

four platforms.
each could be worth £1b.
Redmile invested for Avidimab. Modi1, Modi2, Immunobady and GlyMab were the cherry on the cake.
three platfoms in trials.
each platform could be worth £100m today

GB reminding us of another product line.
i would not be surprised to see more on this in the near future

that Professor Christian has been desprate to start this since before the AGM.

we could get a 1st patient RNS in a matter of a week or so

that in mouse trials solid tumers were melted away in days.
If this works we may see results earlier than excpected